April 10, 2017
U.S. pharma brands jumped in value in Brand Finance’s annual report of the nation’s 500 most valuable brands, with the exception of Valeant Pharmaceuticals. Brand value […]
April 10, 2017
CRISPR Therapeutics reports that the European Patent Office (EPO) has announced its intention to grant a patent broadly covering CRISPR’s in-licensed gene editing technology. The […]
April 14, 2017
Amid criticism of rising prescription drug costs, the 1983 Orphan Drug Act, which granted drugmakers of a rare disease drug seven years of marketing exclusivity, has […]
April 20, 2017
George Church is featured in TIME Magazine’s annual list TIME 100: The Most Influential People of 2017 under the category of “Titans.” TIME’s excerpt on Church […]
May 5, 2017
Despite news about drug pricing and expenses last year, net spending growth actually fell in the US. After discounts, pharma spending increased 4.8% in 2016, down from […]
May 22, 2017
Featuring CEO Interview with Elizabeth Hanna, President, Human Health, and Chief Operating Officer, Origin Your Issue of Ashton Tweed Connection Vol. 4 No. 4 is Here! […]
May 22, 2017
The Senate confirmed Scott Gottlieb, a physician and venture capitalist, as the next commissioner of the Food and Drug Administration (FDA). The vote was 57 to 42. […]
May 22, 2017
Quintiles and IMS Health combined in a megamerger last year, and now INC and inVentiv are doing the same, making it the second largest biopharmaceutical outsourcing […]
May 22, 2017
The FDA has approved Radicava in the US as the first new drug since 1995 to treat ALS. It will be marketed by MT Pharma America, […]